Lumicell attracts $28.7 mln Series C
Wellesley, Massachusetts-based Lumicell, a developer of a novel system that enables real-time detection of tumor tissue in patients, has raised $28.7 million in Series C financing. The investors included Launch Capital and BlueIO.
7 December 2017•1 min read
